PubRank

Anne Klibanski

Author PubWeight™ 177.39‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Activation of p53 by MEG3 non-coding RNA. J Biol Chem 2007 3.07
2 A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells. J Clin Endocrinol Metab 2003 2.68
3 MEG3 noncoding RNA: a tumor suppressor. J Mol Endocrinol 2012 2.41
4 Increased bone marrow fat in anorexia nervosa. J Clin Endocrinol Metab 2009 2.31
5 Uncoupling of cardiovascular risk markers in adolescent girls with anorexia nervosa. J Pediatr 2006 2.06
6 Elevated peptide YY levels in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 2005 2.03
7 Vertebral bone marrow fat is positively associated with visceral fat and inversely associated with IGF-1 in obese women. Obesity (Silver Spring) 2010 1.93
8 Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. J Clin Endocrinol Metab 2004 1.81
9 Visceral fat is a negative predictor of bone density measures in obese adolescent girls. J Clin Endocrinol Metab 2010 1.80
10 Maternally expressed gene 3 (MEG3) noncoding ribonucleic acid: isoform structure, expression, and functions. Endocrinology 2009 1.78
11 Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Res 2010 1.76
12 Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: a randomized, placebo-controlled study. J Clin Endocrinol Metab 2011 1.74
13 Effects of anorexia nervosa on clinical, hematologic, biochemical, and bone density parameters in community-dwelling adolescent girls. Pediatrics 2004 1.73
14 Medical findings in outpatients with anorexia nervosa. Arch Intern Med 2005 1.69
15 Fear conditioning and extinction: influence of sex and menstrual cycle in healthy humans. Behav Neurosci 2006 1.68
16 Fracture risk and areal bone mineral density in adolescent females with anorexia nervosa. Int J Eat Disord 2014 1.64
17 Bone, fat, and body composition: evolving concepts in the pathogenesis of osteoporosis. Am J Med 2009 1.63
18 Marrow fat and bone--new perspectives. J Clin Endocrinol Metab 2013 1.60
19 Abnormal bone mineral accrual in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 2002 1.58
20 FGF21 and the late adaptive response to starvation in humans. J Clin Invest 2015 1.55
21 Estradiol modulates medial prefrontal cortex and amygdala activity during fear extinction in women and female rats. Biol Psychiatry 2011 1.51
22 Alterations in growth hormone secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab 2003 1.49
23 Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J Clin Endocrinol Metab 2002 1.48
24 Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: mortality, morbidity, and the effects of hospital and surgeon volume. J Clin Endocrinol Metab 2003 1.44
25 Secretory dynamics of ghrelin in adolescent girls with anorexia nervosa and healthy adolescents. Am J Physiol Endocrinol Metab 2005 1.43
26 Lower growth hormone and higher cortisol are associated with greater visceral adiposity, intramyocellular lipids, and insulin resistance in overweight girls. Am J Physiol Endocrinol Metab 2008 1.41
27 Hypermethylation of the promoter region is associated with the loss of MEG3 gene expression in human pituitary tumors. J Clin Endocrinol Metab 2005 1.34
28 Secretory dynamics of leptin in adolescent girls with anorexia nervosa and healthy adolescents. Am J Physiol Endocrinol Metab 2005 1.33
29 Selective loss of MEG3 expression and intergenic differentially methylated region hypermethylation in the MEG3/DLK1 locus in human clinically nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 2008 1.33
30 Loss of expression of GADD45 gamma, a growth inhibitory gene, in human pituitary adenomas: implications for tumorigenesis. J Clin Endocrinol Metab 2002 1.29
31 Activation of paternally expressed genes and perinatal death caused by deletion of the Gtl2 gene. Development 2010 1.28
32 Determinants of skeletal loss and recovery in anorexia nervosa. J Clin Endocrinol Metab 2006 1.27
33 Alterations in cortisol secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab 2004 1.26
34 Changing patterns in diagnosis and therapy of acromegaly over two decades. J Clin Endocrinol Metab 2008 1.25
35 Nutrient intake in community-dwelling adolescent girls with anorexia nervosa and in healthy adolescents. Am J Clin Nutr 2006 1.25
36 A critical analysis of pituitary tumor shrinkage during primary medical therapy in acromegaly. J Clin Endocrinol Metab 2005 1.23
37 Comparison of DXA and CT in the assessment of body composition in premenopausal women with obesity and anorexia nervosa. Obesity (Silver Spring) 2010 1.23
38 Distal radius in adolescent girls with anorexia nervosa: trabecular structure analysis with high-resolution flat-panel volume CT. Radiology 2008 1.23
39 Hypercortisolemia is associated with severity of bone loss and depression in hypothalamic amenorrhea and anorexia nervosa. J Clin Endocrinol Metab 2009 1.22
40 Weight gain and restoration of menses as predictors of bone mineral density change in adolescent girls with anorexia nervosa-1. J Clin Endocrinol Metab 2007 1.20
41 Increased expression of angiogenic genes in the brains of mouse meg3-null embryos. Endocrinology 2010 1.19
42 Ipilimumab-induced hypophysitis: a detailed longitudinal analysis in a large cohort of patients with metastatic melanoma. J Clin Endocrinol Metab 2014 1.19
43 Young women with cold-activated brown adipose tissue have higher bone mineral density and lower Pref-1 than women without brown adipose tissue: a study in women with anorexia nervosa, women recovered from anorexia nervosa, and normal-weight women. J Clin Endocrinol Metab 2012 1.18
44 Preadipocyte factor-1 is associated with marrow adiposity and bone mineral density in women with anorexia nervosa. J Clin Endocrinol Metab 2009 1.18
45 Relationships between serum adipokines, insulin levels, and bone density in girls with anorexia nervosa. J Clin Endocrinol Metab 2007 1.18
46 Effects of exercise training and metformin on body composition and cardiovascular indices in HIV-infected patients. AIDS 2004 1.18
47 Decreased nocturnal oxytocin levels in anorexia nervosa are associated with low bone mineral density and fat mass. J Clin Psychiatry 2011 1.17
48 Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosa. J Bone Miner Res 2011 1.16
49 Hormone predictors of abnormal bone microarchitecture in women with anorexia nervosa. Bone 2009 1.15
50 Leptin levels are associated with decreased depressive symptoms in women across the weight spectrum, independent of body fat. Clin Endocrinol (Oxf) 2012 1.14
51 Peptide YY (PYY) levels and bone mineral density (BMD) in women with anorexia nervosa. Bone 2008 1.13
52 The effects of SOM230 on cell proliferation and adrenocorticotropin secretion in human corticotroph pituitary adenomas. J Clin Endocrinol Metab 2006 1.12
53 Bone metabolism in adolescent athletes with amenorrhea, athletes with eumenorrhea, and control subjects. Pediatrics 2008 1.11
54 Marrow fat and preadipocyte factor-1 levels decrease with recovery in women with anorexia nervosa. J Bone Miner Res 2012 1.11
55 Growth hormone decreases visceral fat and improves cardiovascular risk markers in women with hypopituitarism: a randomized, placebo-controlled study. J Clin Endocrinol Metab 2008 1.11
56 Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolism. J Clin Psychiatry 2004 1.11
57 Anorexia nervosa and osteoporosis. Rev Endocr Metab Disord 2006 1.10
58 Regional body composition in adolescents with anorexia nervosa and changes with weight recovery. Am J Clin Nutr 2003 1.09
59 Diagnostic errors after inferior petrosal sinus sampling. J Clin Endocrinol Metab 2004 1.09
60 Endocrine abnormalities in anorexia nervosa. Nat Clin Pract Endocrinol Metab 2008 1.07
61 Food motivation circuitry hypoactivation related to hedonic and nonhedonic aspects of hunger and satiety in women with active anorexia nervosa and weight-restored women with anorexia nervosa. J Psychiatry Neurosci 2012 1.06
62 Role of cortisol in menstrual recovery in adolescent girls with anorexia nervosa. Pediatr Res 2006 1.04
63 Growth hormone (GH) replacement therapy in adult-onset gh deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial. J Clin Endocrinol Metab 2004 1.03
64 Waist to hip ratio and trunk to extremity fat (DXA) are better surrogates for IMCL and for visceral fat respectively than for subcutaneous fat in adolescent girls. Nutr Metab (Lond) 2010 1.02
65 Fibroblast growth factor-21 may mediate growth hormone resistance in anorexia nervosa. J Clin Endocrinol Metab 2009 1.01
66 Silencing of the imprinted DLK1-MEG3 locus in human clinically nonfunctioning pituitary adenomas. Am J Pathol 2011 1.01
67 Oxytocin secretion is associated with severity of disordered eating psychopathology and insular cortex hypoactivation in anorexia nervosa. J Clin Endocrinol Metab 2012 1.01
68 Differential effects of metformin and exercise on muscle adiposity and metabolic indices in human immunodeficiency virus-infected patients. J Clin Endocrinol Metab 2004 1.01
69 Stress response circuitry hypoactivation related to hormonal dysfunction in women with major depression. J Affect Disord 2010 1.01
70 Cortical microstructure and estimated bone strength in young amenorrheic athletes, eumenorrheic athletes and non-athletes. Bone 2012 1.00
71 Effects of recombinant human growth hormone in anorexia nervosa: a randomized, placebo-controlled study. J Clin Endocrinol Metab 2010 1.00
72 Ghrelin and bone metabolism in adolescent girls with anorexia nervosa and healthy adolescents. J Clin Endocrinol Metab 2005 1.00
73 Regional cerebral brain metabolism correlates of neuroticism and extraversion. Depress Anxiety 2006 1.00
74 Growth hormone and ghrelin responses to an oral glucose load in adolescent girls with anorexia nervosa and controls. J Clin Endocrinol Metab 2004 1.00
75 Effects of recombinant human growth hormone therapy in adults with Prader-Willi syndrome: a meta-analysis. Clin Endocrinol (Oxf) 2012 0.99
76 Women with anorexia nervosa: finite element and trabecular structure analysis by using flat-panel volume CT. Radiology 2010 0.98
77 Appetite-regulating hormones cortisol and peptide YY are associated with disordered eating psychopathology, independent of body mass index. Eur J Endocrinol 2010 0.97
78 Hormonal and body composition predictors of soluble leptin receptor, leptin, and free leptin index in adolescent girls with anorexia nervosa and controls and relation to insulin sensitivity. J Clin Endocrinol Metab 2004 0.96
79 Cyclic AMP stimulates MEG3 gene expression in cells through a cAMP-response element (CRE) in the MEG3 proximal promoter region. Int J Biochem Cell Biol 2006 0.96
80 Clinical Review#: Potential cardiac valve effects of dopamine agonists in hyperprolactinemia. J Clin Endocrinol Metab 2010 0.96
81 Effects of rhIGF-1 administration on surrogate markers of bone turnover in adolescents with anorexia nervosa. Bone 2009 0.95
82 Delayed remission after transsphenoidal surgery in patients with Cushing's disease. J Clin Endocrinol Metab 2010 0.95
83 Growth hormone deficiency is associated with decreased quality of life in patients with prior acromegaly. J Clin Endocrinol Metab 2009 0.95
84 Bone metabolism in adolescent boys with anorexia nervosa. J Clin Endocrinol Metab 2008 0.95
85 Serum prolactin levels among outpatients with major depressive disorder during the acute phase of treatment with fluoxetine. J Clin Psychiatry 2006 0.94
86 Neuroendocrine consequences of anorexia nervosa in adolescents. Endocr Dev 2009 0.93
87 Adolescent girls with anorexia nervosa have impaired cortical and trabecular microarchitecture and lower estimated bone strength at the distal radius. J Clin Endocrinol Metab 2013 0.93
88 Hormonal determinants of regional body composition in adolescent girls with anorexia nervosa and controls. J Clin Endocrinol Metab 2005 0.91
89 Increased carbohydrate induced ghrelin secretion in obese vs. normal-weight adolescent girls. Obesity (Silver Spring) 2009 0.91
90 Gonadotropinomas. Semin Reprod Med 2002 0.91
91 Proton stereotactic radiotherapy for persistent adrenocorticotropin-producing adenomas. J Clin Endocrinol Metab 2007 0.91
92 Prognostic indicators of changes in bone density measures in adolescent girls with anorexia nervosa-II. J Clin Endocrinol Metab 2007 0.91
93 Bone health in anorexia nervosa. Curr Opin Endocrinol Diabetes Obes 2011 0.91
94 Effects of risedronate on bone density in anorexia nervosa. J Clin Endocrinol Metab 2004 0.90
95 Proton stereotactic radiosurgery in management of persistent acromegaly. Endocr Pract 2008 0.90
96 Growth hormone deficiency after treatment of acromegaly: a randomized, placebo-controlled study of growth hormone replacement. J Clin Endocrinol Metab 2010 0.90
97 Effects of estrogen and recombinant human insulin-like growth factor-I on ghrelin secretion in severe undernutrition. J Clin Endocrinol Metab 2004 0.90
98 Psychotropic medication use in anorexia nervosa between 1997 and 2009. Int J Eat Disord 2012 0.90
99 Optimizing control of acromegaly: integrating a growth hormone receptor antagonist into the treatment algorithm. J Clin Endocrinol Metab 2003 0.89
100 Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant. J Clin Endocrinol Metab 2002 0.89
101 Effects of recombinant human insulin-like growth factor (IGF)-I and estrogen administration on IGF-I, IGF binding protein (IGFBP)-2, and IGFBP-3 in anorexia nervosa: a randomized-controlled study. J Clin Endocrinol Metab 2003 0.89
102 Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder. Psychiatry Res 2002 0.89
103 Serum osteoprotegerin in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 2003 0.88
104 Acylated ghrelin and leptin in adolescent athletes with amenorrhea, eumenorrheic athletes and controls: a cross-sectional study. Clin Endocrinol (Oxf) 2008 0.88
105 Clinical features of nonpituitary sellar lesions in a large surgical series. Clin Endocrinol (Oxf) 2010 0.88
106 Growth hormone suppression after an oral glucose load in children. J Clin Endocrinol Metab 2007 0.87
107 Current status and future opportunities for controlling acromegaly. Pituitary 2002 0.87
108 Hypoglycemia from IGF2 overexpression associated with activation of fetal promoters and loss of imprinting in a metastatic hemangiopericytoma. J Clin Endocrinol Metab 2009 0.87
109 Peptide YY in adolescent athletes with amenorrhea, eumenorrheic athletes and non-athletic controls. Bone 2009 0.87
110 Cardiovascular risk in patients with growth hormone deficiency: effects of growth hormone substitution. Endocr Pract 2007 0.87
111 Gender effects on cardiac valvular function in hyperprolactinaemic patients receiving cabergoline: a retrospective study. Clin Endocrinol (Oxf) 2009 0.86
112 Teriparatide increases bone formation and bone mineral density in adult women with anorexia nervosa. J Clin Endocrinol Metab 2014 0.86
113 Anorexia nervosa, obesity and bone metabolism. Pediatr Endocrinol Rev 2013 0.86
114 Sclerostin levels and bone turnover markers in adolescents with anorexia nervosa and healthy adolescent girls. Bone 2012 0.85
115 Nocturnal oxytocin secretion is lower in amenorrheic athletes than nonathletes and associated with bone microarchitecture and finite element analysis parameters. Eur J Endocrinol 2013 0.85
116 Receptor internalization-independent activation of Smad2 in activin signaling. Mol Endocrinol 2004 0.85
117 Reduced amylin levels are associated with low bone mineral density in women with anorexia nervosa. Bone 2009 0.85
118 Androgen deficiency: association with increased anxiety and depression symptom severity in anorexia nervosa. J Clin Psychiatry 2007 0.85
119 Brain hypoactivation, autonomic nervous system dysregulation, and gonadal hormones in depression: a preliminary study. Neurosci Lett 2012 0.85
120 Regulation of growth hormone expression by Delta-like protein 1 (Dlk1). Mol Cell Endocrinol 2007 0.85
121 IGFBP-2 is a negative predictor of cold-induced brown fat and bone mineral density in young non-obese women. Bone 2013 0.85
122 Androgens and bone density in women with hypopituitarism. J Clin Endocrinol Metab 2002 0.84
123 Effects of recombinant human growth hormone therapy on bone mineral density in adults with growth hormone deficiency: a meta-analysis. J Clin Endocrinol Metab 2014 0.84
124 Determinants of height in adolescent girls with anorexia nervosa. Pediatrics 2008 0.83
125 Postprandial oxytocin secretion is associated with severity of anxiety and depressive symptoms in anorexia nervosa. J Clin Psychiatry 2013 0.83
126 Simultaneous initiation (coinitiation) of pharmacotherapy with triiodothyronine and a selective serotonin reuptake inhibitor for major depressive disorder: a quantitative synthesis of double-blind studies. Int Clin Psychopharmacol 2009 0.83
127 Testosterone administration attenuates regional brain hypometabolism in women with anorexia nervosa. Psychiatry Res 2004 0.83
128 Positive effects of brown adipose tissue on femoral bone structure. Bone 2013 0.83
129 Transsphenoidal surgery for cushing disease after nondiagnostic inferior petrosal sinus sampling. Neurosurgery 2012 0.83
130 Comparison of hip geometry, strength, and estimated fracture risk in women with anorexia nervosa and overweight/obese women. J Clin Endocrinol Metab 2014 0.82
131 Body composition and skeletal health: too heavy? Too thin? Curr Osteoporos Rep 2012 0.82
132 Management of recurrent and refractory Cushing's disease with reoperation and/or proton beam radiosurgery. Clin Neurosurg 2008 0.82
133 Bone metabolism in anorexia nervosa. Curr Osteoporos Rep 2014 0.82
134 Inhibition of Pref-1 (preadipocyte factor 1) by oestradiol in adolescent girls with anorexia nervosa is associated with improvement in lumbar bone mineral density. Clin Endocrinol (Oxf) 2013 0.82
135 Effects of growth hormone secretion on body composition in patients with Crohn's disease. J Clin Endocrinol Metab 2003 0.82
136 Endocrinology of anorexia nervosa in young people: recent insights. Curr Opin Endocrinol Diabetes Obes 2014 0.82
137 Isolation and characterization of novel pituitary tumor related genes: a cDNA representational difference approach. Mol Cell Endocrinol 2010 0.81
138 Hip structural analysis in adolescent boys with anorexia nervosa and controls. J Clin Endocrinol Metab 2013 0.81
139 Hormonal and nutritional effects on cardiovascular risk markers in young women. J Clin Endocrinol Metab 2007 0.81
140 Growth hormone is positively associated with surrogate markers of bone turnover during puberty. Clin Endocrinol (Oxf) 2011 0.81
141 Increased hypothalamic-pituitary-adrenal drive is associated with decreased appetite and hypoactivation of food-motivation neurocircuitry in anorexia nervosa. Eur J Endocrinol 2013 0.81
142 Impact of physiologic estrogen replacement on anxiety symptoms, body shape perception, and eating attitudes in adolescent girls with anorexia nervosa: data from a randomized controlled trial. J Clin Psychiatry 2013 0.81
143 Percentage extremity fat, but not percentage trunk fat, is lower in adolescent boys with anorexia nervosa than in healthy adolescents. Am J Clin Nutr 2008 0.81
144 The neuroendocrine basis of anorexia nervosa and its impact on bone metabolism. Neuroendocrinology 2011 0.80
145 Pathologic and clinical features of pituitary adenomas showing TSH immunoreactivity. Pituitary 2013 0.80
146 Adipokines and cardiovascular risk in Cushing's syndrome. Neuroendocrinology 2011 0.79
147 Effect of growth hormone replacement therapy on the quality of life in women with growth hormone deficiency who have a history of acromegaly versus other disorders. Endocr Pract 2012 0.79
148 Appetite regulatory hormones in women with anorexia nervosa: binge-eating/purging versus restricting type. J Clin Psychiatry 2015 0.79
149 The treatment of hyperprolactinemia in postmenopausal women with prolactin-secreting microadenomas: cons. Endocrine 2014 0.79
150 Overexpression of wild-type activin receptor alk4-1 restores activin antiproliferative effects in human pituitary tumor cells. J Clin Endocrinol Metab 2002 0.78
151 Determinants of GH resistance in malnutrition. J Endocrinol 2014 0.78
152 Growth hormone status predicts left ventricular mass in patients after cure of acromegaly. Growth Horm IGF Res 2010 0.78
153 Effects of long-term growth hormone replacement in adults with growth hormone deficiency following cure of acromegaly: a KIMS analysis. J Clin Endocrinol Metab 2014 0.78
154 Peptide YY levels across pubertal stages and associations with growth hormone. J Clin Endocrinol Metab 2010 0.78
155 Concomitant medication use can confound interpretation of the combined dexamethasone-corticotropin releasing hormone test in Cushing's syndrome. J Clin Endocrinol Metab 2009 0.78
156 Reciprocal changes in endogenous ghrelin and growth hormone during fasting in healthy women. Am J Physiol Endocrinol Metab 2005 0.77
157 Anorexia Nervosa and Its Associated Endocrinopathy in Young People. Horm Res Paediatr 2016 0.77
158 The effect of somatostatin analogs on vitamin D and calcium concentrations in patients with acromegaly. Pituitary 2014 0.77
159 Dopamine agonist therapy in prolactinomas: when can treatment be discontinued? J Clin Endocrinol Metab 2009 0.77
160 Bone density characteristics and major depressive disorder in adolescents. Psychosom Med 2013 0.77
161 Hypercalcemia and local production of parathyroid hormone-related protein by a perisellar rhabdomyosarcoma after remote pituitary irradiation. Endocr Pract 2005 0.76
162 Investigation of impulsivity in patients on dopamine agonist therapy for hyperprolactinemia: a pilot study. Pituitary 2014 0.76
163 Growth hormone should be used only for approved indications. J Clin Endocrinol Metab 2013 0.76
164 Evaluation and treatment of low bone density in anorexia nervosa. Nutr Clin Care 2003 0.76
165 Central diabetes insipidus: a previously unreported side effect of temozolomide. J Clin Endocrinol Metab 2013 0.75
166 A patient with diabetes insipidus, anterior hypopituitarism and pituitary stalk thickening. Nat Rev Endocrinol 2010 0.75
167 Plasma sodium level is associated with bone loss severity in women with anorexia nervosa: a cross-sectional study. J Clin Psychiatry 2012 0.75
168 Sex differences in episodic memory in early midlife: impact of reproductive aging. Menopause 2016 0.75
169 Erratum to: Impact of low-weight severity and menstrual status on bone in adolescent girls with anorexia nervosa. Int J Eat Disord 2017 0.75
170 Diabetes insipidus. J Clin Endocrinol Metab 2013 0.75
171 Corrigendum: Region-specific variation in the properties of skeletal adipocytes reveals regulated and constitutive marrow adipose tissues. Nat Commun 2016 0.75
172 Traumatic brain injury: effects on the endocrine system. J Clin Endocrinol Metab 2013 0.75
173 The role of the clinical laboratory in the diagnosis of Cushing syndrome. Am J Clin Pathol 2003 0.75